The EC has approved argenx’s Vyvgart (efgartigimod alfa) 1000mg as a single agen...
David W Miller, CEO of Genesis Research Group, discusses how pharma's decade-lon...
In a groundbreaking study set to redefine neonatal nutritional strategies, resea...
The phenomenon of women giving birth after the age of 40 has become increasingly...
In a groundbreaking advancement poised to redefine the frontiers of ultrafast ph...
In a groundbreaking advancement poised to redefine renewable energy technologies...
In a significant revelation regarding the complexities of plastic recycling, a g...
In a groundbreaking development that bridges ancient microbial menaces with cutt...
A groundbreaking discovery in melanoma research has unveiled a crucial biologica...
In a groundbreaking advancement poised to revolutionize oncological treatment, s...
In a groundbreaking study published in Nature Communications, researchers have u...
In a groundbreaking study published recently in Cell Death Discovery, researcher...
In the relentless quest to understand Parkinson’s disease, a neurodegenerative d...
In a groundbreaking study poised to redefine our understanding of glioblastoma b...
In the wake of the COVID-19 pandemic, urban environments experienced profound tr...
In a groundbreaking study poised to shift the paradigm of lung cancer treatment,...
